PL3643325T3 - Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania - Google Patents
Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzaniaInfo
- Publication number
- PL3643325T3 PL3643325T3 PL19209609.7T PL19209609T PL3643325T3 PL 3643325 T3 PL3643325 T3 PL 3643325T3 PL 19209609 T PL19209609 T PL 19209609T PL 3643325 T3 PL3643325 T3 PL 3643325T3
- Authority
- PL
- Poland
- Prior art keywords
- furazidin
- manufacturing
- composition
- Prior art date
Links
- DECBQELQORZLLP-UAIOPKHMSA-N 1-[(e)-[(e)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione Chemical compound O1C([N+](=O)[O-])=CC=C1\C=C\C=N\N1C(=O)NC(=O)C1 DECBQELQORZLLP-UAIOPKHMSA-N 0.000 title 1
- 229960002375 furazidin Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL419047A PL234271B1 (pl) | 2016-10-10 | 2016-10-10 | Doustna kompozycja farmaceutyczna zawierająca furazydynę w postaci zawiesiny oraz sposoby jej wytwarzania |
| PL421505A PL234395B1 (pl) | 2017-05-08 | 2017-05-08 | Doustna kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3643325T3 true PL3643325T3 (pl) | 2024-06-24 |
Family
ID=60302423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19209609.7T PL3643325T3 (pl) | 2016-10-10 | 2017-10-06 | Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP3643325B1 (pl) |
| PL (1) | PL3643325T3 (pl) |
| RU (1) | RU2019110218A (pl) |
| WO (1) | WO2018069804A2 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL236891B1 (pl) * | 2017-06-21 | 2021-02-22 | Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia | Płynna forma podawania furazydyny oraz sposób jej otrzymywania |
| HUE071463T2 (hu) * | 2021-01-25 | 2025-08-28 | Adamed Pharma S A | Elnyújtott hatóanyag-leadású furazidinkészítmény |
| EP4545074A1 (en) | 2023-10-27 | 2025-04-30 | Adamed Pharma S.A. | Pharmaceutical composition of furazidin for vaginal administration |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4500516A (en) * | 1982-10-22 | 1985-02-19 | Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr | Antibacterial pharmaceutical composition |
| RU2103997C1 (ru) * | 1995-04-19 | 1998-02-10 | Акционерное общество закрытого типа "Гекта" | Лекарственное средство для лечения заболеваний животных микробной этиологии, способ лечения желудочно-кишечных заболеваний животных микробной этиологии и способы лечения гинекологических заболеваний коров микробной этиологии |
| RU2626671C2 (ru) * | 2015-08-05 | 2017-07-31 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Нижегородская государственная медицинская академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО НижГМА Минздрава России) | Лекарственное средство для лечения поражений мягких тканей организма |
-
2017
- 2017-10-06 EP EP19209609.7A patent/EP3643325B1/en active Active
- 2017-10-06 WO PCT/IB2017/056199 patent/WO2018069804A2/en not_active Ceased
- 2017-10-06 PL PL19209609.7T patent/PL3643325T3/pl unknown
- 2017-10-06 EP EP17797439.1A patent/EP3522929A2/en active Pending
- 2017-10-06 RU RU2019110218A patent/RU2019110218A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP3522929A2 (en) | 2019-08-14 |
| WO2018069804A2 (en) | 2018-04-19 |
| EP3643325B1 (en) | 2024-04-10 |
| WO2018069804A3 (en) | 2018-07-19 |
| EP3643325C0 (en) | 2024-04-10 |
| RU2019110218A3 (pl) | 2021-03-30 |
| RU2019110218A (ru) | 2020-11-13 |
| EP3643325A1 (en) | 2020-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202004253QA (en) | Oil-and-fat composition and manufacturing method thereof | |
| PL3206816T3 (pl) | Sposób wytwarzania elementu składowego i element składowy | |
| GB2526633B (en) | Garment and method of manufacturing same | |
| PL3484318T3 (pl) | Czapka z daszkiem i sposób wytwarzania czapki z daszkiem | |
| PT3036748T (pt) | Indutor e respetivo método de fabrico | |
| PL3377146T3 (pl) | Mikropompa i sposób wytwarzania mikropompy | |
| ZA201906944B (en) | Methods of manufacturing of niraparib | |
| PL3178980T3 (pl) | Materiał włókienniczy oraz sposób wytwarzania materiału włókienniczego | |
| GB201716774D0 (en) | Method of manufacturing fluorescent-material-containing member | |
| EP3116069A4 (en) | Terminal and method of manufacturing a terminal | |
| SG10201607486YA (en) | Improved packaging and method of manufacturing same | |
| GB201604320D0 (en) | Display and method of manufacturing same | |
| PL3127605T3 (pl) | Sposób wytwarzania wypełnienia oraz wypełnienie | |
| SG11201609688QA (en) | Formed material manufacturing method and formed material | |
| GB2548706B (en) | Method of manufacturing fluorescent-material-containing member | |
| SG11201507205UA (en) | Formed material manufacturing method and formed material | |
| SG10201912645TA (en) | Free-polyunsaturated-fatty-acid-containing composition and method for manufacturing same | |
| SI3325839T1 (sl) | Oblikovani material in postopek proizvodnje | |
| PL3643325T3 (pl) | Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania | |
| SG11202006477WA (en) | Methionine-metal chelate and manufacturing method thereof | |
| GB201603001D0 (en) | A bearing raceaway and a method of manufacturing a bearing | |
| GB201503137D0 (en) | A decal and a method of manufacturing same | |
| SG11202000339WA (en) | Methionine-Metal Chelate and Manufacturing Method thereof | |
| GB201501413D0 (en) | A confectionery composition and a method of manufacturing thereof | |
| GB2552007C (en) | Horseshoe and method of manufacturing a horseshoe |